BIOGEN INC. Equity Securities, FV-NI, Realized Gain (Loss)
BIOGEN INC. (BIIB) reported Equity Securities, FV-NI, Realized Gain (Loss) of -$3.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-04-29
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-31 was -$3.20M.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-12-31 was -$100.00K, a 102.94% decline year-over-year.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-09-30 was $7.00M.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for fiscal 2025 was $1.50M.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for fiscal 2024 was -$2.00M, a 138.46% decline from fiscal 2023.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $5.20M.
- BIOGEN INC. equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 3 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 12 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$3.20M 10-Q · filed 2026-04-29 | -$3.30M derived: sum of 2 quarters · filed 2026-04-29 | $3.70M derived: sum of 3 quarters · filed 2026-04-29 | $3.70M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $6.90M derived: sum of 2 quarters · filed 2026-02-06 | $6.90M derived: sum of 3 quarters · filed 2026-02-06 | $1.50M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $7.00M 10-Q · filed 2025-10-30 | $7.00M derived: sum of 2 quarters · filed 2025-10-30 | $1.60M 10-Q · filed 2025-10-30 | $5.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | -$5.40M 10-Q · filed 2025-07-31 | -$2.00M derived: sum of 3 quarters · filed 2026-04-29 | -$12.90M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$5.40M 10-Q · filed 2026-04-29 | -$2.00M derived: sum of 2 quarters · filed 2026-04-29 | -$12.90M derived: sum of 3 quarters · filed 2026-04-29 | -$12.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$7.50M derived: sum of 2 quarters · filed 2026-02-06 | -$6.90M derived: sum of 3 quarters · filed 2026-02-06 | -$2.00M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$10.90M 10-Q · filed 2025-10-30 | -$10.30M derived: sum of 2 quarters · filed 2025-10-30 | -$5.40M 10-Q · filed 2025-10-30 | -$5.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $600.00K 10-Q · filed 2025-07-31 | $5.50M 10-Q · filed 2025-07-31 | $5.40M derived: sum of 3 quarters · filed 2026-02-06 | $9.80M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-01 | $4.80M derived: sum of 2 quarters · filed 2026-02-06 | $9.20M derived: sum of 3 quarters · filed 2026-02-06 | $8.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $4.30M derived: sum of 2 quarters · filed 2026-02-06 | $3.60M derived: sum of 3 quarters · filed 2026-02-06 | $5.20M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $4.40M 10-Q · filed 2024-10-30 | $3.70M derived: sum of 2 quarters · filed 2024-10-30 | $5.30M 10-Q · filed 2024-10-30 | $5.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$700.00K 10-Q · filed 2024-08-01 | $900.00K 10-Q · filed 2024-08-01 | $900.00K derived: sum of 3 quarters · filed 2025-02-12 | $400.00K derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $1.60M 10-Q · filed 2024-04-24 | $1.60M derived: sum of 2 quarters · filed 2025-02-12 | $1.10M derived: sum of 3 quarters · filed 2025-02-12 | $1.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$500.00K derived: sum of 2 quarters · filed 2025-02-12 | $200.00K derived: sum of 3 quarters · filed 2025-02-12 | $0.00 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$500.00K 10-Q · filed 2023-11-08 | $200.00K derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | -$1.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $700.00K 10-Q · filed 2023-07-25 | -$700.00K 10-Q · filed 2022-07-20 | $500.00K 10-Q · filed 2023-07-25 | -$500.00K 10-Q · filed 2022-07-20 | -$500.00K derived: sum of 3 quarters · filed 2024-02-14 | -$3.20M derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2022-03-31 | -$200.00K 10-Q · filed 2023-04-25 | $200.00K 10-Q · filed 2022-05-03 | -$1.20M derived: sum of 2 quarters · filed 2024-02-14 | -$3.90M derived: sum of 3 quarters · filed 2024-02-14 | -$3.50M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$3.70M derived: sum of 2 quarters · filed 2024-02-14 | -$3.30M derived: sum of 3 quarters · filed 2024-02-14 | -$10.30M 10-K · filed 2024-02-14 | $10.30M 10-K · filed 2022-02-03 | |||
| 2021-09-30 | -$2.70M 10-Q · filed 2022-10-25 | $2.70M 10-Q · filed 2021-10-20 | -$2.30M derived: sum of 2 quarters · filed 2022-10-25 | -$9.30M 10-Q · filed 2022-10-25 | $9.30M 10-Q · filed 2021-10-20 | -$8.20M derived: sum of 4 quarters · filed 2023-02-15 | ||
| 2021-06-30 | $400.00K 10-Q · filed 2022-07-20 | $6.60M 10-Q · filed 2022-07-20 | -$5.50M derived: sum of 3 quarters · filed 2023-02-15 | -$5.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $6.20M 10-Q · filed 2022-05-03 | -$5.90M derived: sum of 2 quarters · filed 2023-02-15 | -$5.90M derived: sum of 3 quarters · filed 2023-02-15 | -$5.90M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$12.10M derived: sum of 2 quarters · filed 2023-02-15 | -$12.10M derived: sum of 3 quarters · filed 2023-02-15 | -$12.10M 10-K · filed 2023-02-15 | $12.10M 10-K · filed 2021-02-03 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-10-20 | $0.00 derived: sum of 2 quarters · filed 2021-10-20 | $0.00 10-Q · filed 2021-10-20 | $96.80M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-22 | $0.00 10-Q · filed 2021-07-22 | $96.80M derived: sum of 3 quarters · filed 2022-02-03 | $101.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-22 | $96.80M derived: sum of 2 quarters · filed 2022-02-03 | $101.20M derived: sum of 3 quarters · filed 2022-02-03 | $58.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $96.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $101.20M derived: sum of 2 quarters · filed 2022-02-03 | $58.30M derived: sum of 3 quarters · filed 2022-02-03 | $50.00M 10-K · filed 2022-02-03 | -$50.00M 10-K · filed 2020-02-06 | |||
| 2019-09-30 | $4.40M 10-Q · filed 2020-10-21 | -$4.40M 10-Q · filed 2019-10-22 | -$38.50M derived: sum of 2 quarters · filed 2020-10-21 | -$46.80M 10-Q · filed 2020-10-21 | -$38.80M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-06-30 | -$42.90M 10-Q · filed 2020-07-22 | $42.90M 10-Q · filed 2019-07-24 | -$42.40M 10-Q · filed 2020-07-22 | -$43.20M derived: sum of 3 quarters · filed 2021-02-03 | -$43.20M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-03-31 | $800.00K 10-Q · filed 2020-04-23 | -$300.00K derived: sum of 2 quarters · filed 2021-02-03 | -$300.00K derived: sum of 3 quarters · filed 2021-02-03 | -$300.00K derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$1.10M derived: sum of 2 quarters · filed 2021-02-03 | -$1.10M derived: sum of 3 quarters · filed 2021-02-03 | -$600.00K 10-K · filed 2021-02-03 | $600.00K 10-K · filed 2020-02-06 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-22 | $0.00 derived: sum of 2 quarters · filed 2019-10-22 | $500.00K 10-Q · filed 2019-10-22 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 | $500.00K 10-Q · filed 2019-07-24 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |